Pharmaeokinetic Studies of PEG-dipeptide-TNF-α and in Rat Plasma by ~(125)I-Labeled and Extracting Methods

Zhang Qiang
2011-01-01
Abstract:Objective:To develop a method for extracting all of PEG in rat plasma and to study the pharmacokinetics profile of PEG-Dipeptide-TNF-α conjugates in rat.Method:PEG-Dipeptide-TNF-α labeled by ~(125)Ⅰ isotopes,extracting general PEG was extracted from plasma by chloroform and validated by the method of two-phase spectrophotometry,then detecting radioactive counting of the substances extracted from rat plasma by radio-immunity Gamma counter and counting parameters by curve fitting with 3P87 pharmacokinetics software.Results:The plasma samples were extracted by chloroform after freeze drying,and the results of two-phase spectrophotometry were that the relative recoveries of the three samples were about 100% and the RSD less than 3%,that is to say,the samples possessing known radioactive counting were not influenced by endogenous substances in blank plasma.The result of counting with 3P87 pharmacokinetics software showed that the half-time(t1/2) of TNF-α and PEG-Dipeptide-TNF-α was 0.31h and 21.22h,respectively,and indicated that the new-type PEG modification technology can extend the half-time of TNF-α.Conclusion:The method of extracting all of PEG from plasma was established,that was not only excellent in specificity,separability and operability,but also cheaper and was consonant with bioequiavailability guideline on basic requirements analyzing biological sample.
What problem does this paper attempt to address?